Janisch, Florian http://orcid.org/0000-0003-0517-0482
Klotzbücher, Thomas
Marks, Phillip
Kienapfel, Christina
Meyer, Christian P.
Yu, Hang
Fühner, Constantin
Hillemacher, Tobias
Mori, Keiichiro
Mostafei, Hadi
Shariat, Shahrokh F.
Fisch, Margit
Dahlem, Roland
Rink, Michael
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 7 November 2020
Accepted: 3 February 2021
First Online: 1 March 2021
Compliance with ethical standards
:
: Prof. Sharokh F. Shariat is consulting or advising the following: Astra Zeneca, BMS, Ferring, Ipsen, Jansen, MSD, Olympus, Pfizer, Pierre Fabre, Richard Wolf, Roche, Sanochemia, and Urogen. Dr. Rink is a speaker for Bayer Healthcare, Bristol Myer Squibb, EUSA Pharma, IPSEN Pharma, Novartis, Roche, and Pfizer. Dr. Rink is a consultant and/or received honoraria by Bayer Healthcare, Bristol Myer Squibb, IPSEN Pharma, MSD, Novartis, Roche, and Pfizer. The other authors do not have conflicts of interest present.
: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.